Here are three notes:
1. The total transaction was valued at $770,000, at an average stock price per share of $22.
2. The highest price target for the stock is $26 and the lowest is $19.
3. The company has a market cap of $32.87 billion.
More articles on GI/endoscopy:
NY State Assemblyman introduces Upper Endoscopy Reform Act: 3 things to know
Certain mouth bacteria could help predict pancreatic cancer risk: 3 notes
Gastroenterologist Dr. Brian Levatino named 2016 Health Care Hero: 3 points
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
